Trials / Not Yet Recruiting
Not Yet RecruitingNCT06867796
A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults
A Phase 1 Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of TL-001 in Healthy Adult Participants
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- TrueLab Biopharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to evaluate safety, tolerability, pharmacokinetics (PK)), pharmacodynamics (PD) and immunogenicity of single and multiple ascending dose of TL-001 in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TL-001 | Intravenously administered |
| DRUG | Placebo | Intravenously administered |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2025-03-10
- Last updated
- 2025-03-13
Source: ClinicalTrials.gov record NCT06867796. Inclusion in this directory is not an endorsement.